Detalhe da pesquisa
1.
[Treatment outcome of latent tuberculosis infection in persons with fibrotic pulmonary lesions].
Nihon Koshu Eisei Zasshi
; 68(6): 405-411, 2021 Jun 25.
Artigo
em Japonês
| MEDLINE | ID: mdl-33790095
2.
Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer.
Osaka City Med J
; 62(2): 77-84, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721582
3.
The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer.
Osaka City Med J
; 61(2): 105-12, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26995854
4.
Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015-2021.
Jpn J Infect Dis
; 77(1): 21-24, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37779028
5.
Reaction of plasma adiponectin level in non-small cell lung cancer patients treated with EGFR-TKIs.
Osaka City Med J
; 59(1): 53-60, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23909081
6.
Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.
Osaka City Med J
; 59(1): 45-52, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23909080
7.
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(6): 1162-1171, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791474
8.
A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).
Cancer
; 118(24): 6126-35, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674529
9.
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer.
BMC Cancer
; 12: 568, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23207012
10.
Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population.
Osaka City Med J
; 58(1): 25-34, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23094511
11.
[Carcinomatous meningitis in a post-operative patient with lung adenocarcinoma for which erlotinib was effective - a case report].
Gan To Kagaku Ryoho
; 39(4): 633-5, 2012 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-22504691
12.
Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs.
Int J Cancer
; 129(6): 1410-6, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21128242
13.
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
Jpn J Clin Oncol
; 41(1): 25-31, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20802006
14.
Clinical outcome of amrubicin therapy according to the prior chemotherapy sensitivities of extensive small cell lung cancer.
Osaka City Med J
; 57(2): 59-66, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22443079
15.
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Lancet Oncol
; 11(2): 121-8, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20022809
16.
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer.
Anticancer Res
; 41(10): 5007-5014, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593449
17.
Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities.
Anticancer Drugs
; 20(6): 513-8, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19352172
18.
[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 7. Lung cancer treatment in elderly and/or high risk patients].
Nihon Naika Gakkai Zasshi
; 103(6): 1346-54, 2014 Jun 10.
Artigo
em Japonês
| MEDLINE | ID: mdl-25151800
19.
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial.
Anticancer Res
; 39(4): 2053-2059, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952749
20.
Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Final Report.
Am J Clin Oncol
; 41(10): 967-971, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045265